EMEA-000709-PIP01-09-M05

  • Email
  • Help

Overview

Product details for Inovelon
Invented nameInovelon
Active substance

Rufinamide

Decision numberP/0116/2016
PIP numberEMEA-000709-PIP01-09-M05
Pharmaceutical form(s)Tablet; Oral suspension
Condition(s)/indication(s)

Treatment of Lennox-Gastaut Syndrome

Route(s) of administrationOral use
PIP applicant

Eisai Limited
United Kingdom
Tel. +44 (0)8456 761400
E-mail: eumedinfo@eisai.net

Decision typePM: decision on the application for modification of an agreed PIP

Decision